DERMATAN SULFATE UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD

General description

Dermatan sulfate is a glycosaminoglycan (GAG) that is mainly located in the skin and is also found in various mammalian tissues. It is made up of repeating units of N-acetyl-d-galactosamine (GalNAc) and l-iduronic acid (IdoA). Dermatan sulfate interacts with proteoglycans and plays a role in regulating several biological activities, including coagulation, angiogenesis, tumor migration, and growth factor expression.
Dermatan sulfate USP reference standard is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

The Dermatan sulfate USP reference standard is intended for use in specified quality tests and assays. It is also used to prepare system suitability solution for chromatographic identity using liquid chromatography coupled to a UV detector according to the monograph of United States Pharmacopeia (USP).
Further information is available in the monograph, Heparin Sodium, USP43-NF38 - 2195 of the USP (United States Pharmacopeia).

This USP reference standard is intended for use in specified quality tests and assays.
Also used to prepare system suitability solution according to the United States Pharmacopeia (USP) monograph― Heparin Sodium.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  Ã¢â‚¬â€¹

Other Notes

This product is intended for use as a reference standard in pharmaceutical research and development. It is not tested for animal or human consumption, clinical testing, or therapeutic use.

Sales restrictions may apply.